CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+6.25%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$17.4B
AUM Growth
+$904M
(+5.5%)
Cap. Flow
+$91.5M
Cap. Flow
% of AUM
0.53%
Top 10 Holdings %
Top 10 Hldgs %
29.78%
Holding
731
New
36
Increased
329
Reduced
218
Closed
40
Top Buys
| 1 |
Amgen
AMGN
|
$65.4M |
| 2 |
Amazon
AMZN
|
$57.7M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$54.5M |
| 4 |
BioNTech
BNTX
|
$41.3M |
| 5 |
Advanced Micro Devices
AMD
|
$40.5M |
Top Sells
| 1 |
Lam Research
LRCX
|
$122M |
| 2 |
Thermo Fisher Scientific
TMO
|
$63.5M |
| 3 |
Applied Materials
AMAT
|
$43.1M |
| 4 |
Nu Holdings
NU
|
$36.4M |
| 5 |
Incyte
INCY
|
$33.7M |
Sector Composition
| 1 | Technology | 31.8% |
| 2 | Healthcare | 28.54% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 7.84% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Rhythm Pharmaceuticals
RYTM
$6.78B
| $20.7M | 0.12% |
395,377
+123,979
| +46% | +$6.49M |
|
177
Arcellx
ACLX
$4.03B
| $20.1M | 0.12% |
240,363
+23,355
| +11% | +$1.95M |
|
178
Keros Therapeutics
KROS
$633M
| $20.1M | 0.12% |
345,384
-96,471
| -22% | -$5.6M |
|
179
Jackson Financial
JXN
$6.65B
| $20M | 0.11% |
219,097
-13,449
| -6% | -$1.23M |
|
180
Vera Therapeutics
VERA
$1.54B
| $19.9M | 0.11% |
450,992
+157,232
| +54% | +$6.95M |
|
181
Mirum Pharmaceuticals
MIRM
$3.82B
| $19.8M | 0.11% |
508,475
| – | – |
|
182
Apellis Pharmaceuticals
APLS
$3.55B
| $19.6M | 0.11% |
680,058
+137,023
| +25% | +$3.95M |
|
183
Moody's
MCO
$89.5B
| $19.3M | 0.11% |
40,711
+1,695
| +4% | +$804K |
|
184
Syndax Pharmaceuticals
SNDX
$1.47B
| $19.2M | 0.11% |
998,619
+28,513
| +3% | +$549K |
|
185
United Rentals
URI
$62.7B
| $19.1M | 0.11% |
23,553
-2,037
| -8% | -$1.65M |
|
186
AutoZone
AZO
$70.6B
| $19M | 0.11% |
6,031
+20
| +0.3% | +$63K |
|
187
United Parcel Service
UPS
$72.1B
| $19M | 0.11% |
139,154
+73,792
| +113% | +$10.1M |
|
188
Clean Harbors
CLH
$12.7B
| $18.9M | 0.11% |
78,353
-14,906
| -16% | -$3.6M |
|
189
MasTec
MTZ
$14B
| $18.7M | 0.11% |
152,109
-901
| -0.6% | -$111K |
|
190
Summit Therapeutics
SMMT
$19.3B
| $18.6M | 0.11% |
+850,403
| New | +$18.6M |
|
191
Xenon Pharmaceuticals
XENE
$3.02B
| $18.3M | 0.1% |
463,861
-57,975
| -11% | -$2.28M |
|
192
Canadian Imperial Bank of Commerce
CM
$72.8B
| $18.2M | 0.1% |
296,702
-104,046
| -26% | -$6.39M |
|
193
Oracle
ORCL
$654B
| $18.2M | 0.1% |
106,576
+3,462
| +3% | +$590K |
|
194
Illumina
ILMN
$15.7B
| $18M | 0.1% |
138,270
-66,773
| -33% | -$8.71M |
|
195
Olema Pharmaceuticals
OLMA
$570M
| $18M | 0.1% |
1,506,764
+448,091
| +42% | +$5.35M |
|
196
Legend Biotech
LEGN
$6.66B
| $17.8M | 0.1% |
365,987
+104,952
| +40% | +$5.11M |
|
197
Kura Oncology
KURA
$713M
| $17.7M | 0.1% |
906,482
| – | – |
|
198
GoDaddy
GDDY
$20.1B
| $17.6M | 0.1% |
112,430
+96,813
| +620% | +$15.2M |
|
199
Target
TGT
$42.3B
| $17.6M | 0.1% |
112,884
+16,952
| +18% | +$2.64M |
|
200
Dover
DOV
$24.4B
| $17.5M | 0.1% |
91,488
-369
| -0.4% | -$70.7K |
|